How to take moboxetinib/mobotinib correctly

Before starting treatment with Mobocertinib, patients should have a detailed discussion and evaluation with their physician to determine whether Mobocertinib is appropriate for treatment. The doctor will develop an appropriate treatment plan based on the patient's specific situation and inform the patient of the dosage, time, and method of medication.

1. Correct dosage: Mobosetinib is usually supplied in the form of oral capsules. Patients should take the specified dose per day as recommended by their doctor. Patients can take 160 mg orally once daily and ensure that the capsules are intact and do not crush or chew. It can be taken on an empty stomach or with food to increase the absorption efficiency of the drug.

2. Dietary precautions: Mobosetinib can be taken with or without food. Certain foods and drugs may affect the absorption and effectiveness of mobosertinib, so patients should avoid interacting with specific foods or drugs provided by their doctor while taking the drug. Avoid drinking grapefruit juice, as it may interfere with the absorption of your medications.

3. Regular follow-up and adjustment: The efficacy of mobosetinib may vary depending on individual patient differences, so regular follow-up becomes an important part of the treatment process. The doctor will make adjustments according to the patient's condition and physical condition to ensure the best effect of the treatment. During the follow-up process, patients should proactively report any physical reactions or discomforts during medication to the doctor so that the treatment plan can be adjusted in a timely manner.

4. Treatment of adverse reactions: Although moboxetinib is an effective anti-lung cancer drug, some adverse reactions may still occur during use. Patients should be aware of possible adverse reactions and follow their doctor's recommendations for management. Some common side effects may include nausea, vomiting, diarrhea, rash, etc.

5. Warning: Mobosetinib can cause life-threatening heart rate correctionsQT (QTc) prolongation, including torsade de pointes, which may be fatal and requires QTc and electrolyte monitoring at baseline and periodically during treatment. Increase the frequency of monitoring in patients with risk factors for QTc prolongation. Avoid concomitant drugs known to prolong the QTc interval, as well as strong or moderate CYP3A inhibitors that may further prolong QTc.

6. Other precautions: Patients should strictly abide by the treatment plan given by the doctor and do not stop or change the dosage unless instructed by the doctor. At the same time, patients should maintain a positive attitude and cooperate with the doctor's treatment and suggestions in order to obtain the best treatment effect.

Mobosetinib The original drug has been launched in China, but it is not included in the medical insurance. The price of the common specification 40mg*112 pills per box is about 40,000 yuan, which is very high. The Hong Kong clinical version specification 40mg*30 pills per box is priced at more than 7,000 yuan (the price may fluctuate due to exchange rates). Generic drugs of Mobotinib are already on the market overseas, The drug ingredients are basically the same as those of original drugs at home and abroad. For example, the price of the Laos pharmaceutical factory's production specification of 40mg*120 capsules per box may be more than 4,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.